Evidence map›Paper›PMID 29518939›Full record

ArticleInternational journal of molecular sciences2018

Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.

Ombretta Repetto, Stefania Maiero, Raffaella Magris, Gianmaria Miolo, Maria Rita Cozzi, Agostino Steffan, Vincenzo Canzonieri, Renato Cannizzaro, Valli De Re

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Molecular Features Distinguish Gastric Cancer Subtypes.International journal of molecular sciences · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ombretta RepettoFacility of Bio-Proteomics, Immunopathology and Cancer Biomarkers, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. orepetto@cro.it.ORCID 0000-0002-0785-5066
Stefania MaieroGastroenterology, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. smaiero@cro.it.
Raffaella MagrisGastroenterology, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. raffaella.magris@cro.it.
Gianmaria MioloMedical Oncology, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. gmiolo@cro.it.
Maria Rita CozziImmunopathology and Cancer Biomarkers, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. mrcozzi@cro.it.
Agostino SteffanImmunopathology and Cancer Biomarkers, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. asteffan@cro.it.
Vincenzo CanzonieriPathology, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. vcanzonieri@cro.it.
Renato CannizzaroGastroenterology, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. rcannizzaro@cro.it.ORCID 0000-0002-2020-222X
Valli De ReFacility of Bio-Proteomics, Immunopathology and Cancer Biomarkers, CRO Aviano National Cancer Institute, 33081 Aviano, Italy. vdere@cro.it.ORCID 0000-0001-6100-9373

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated plasma fibrinogen levels and tumor progression in patients with gastric cancer (GC) have been largely reported. However, distinct fibrinogen chains and domains have different effects on coagulation, inflammation, and angiogenesis. The aim of this study was to characterize fibrinogen β chain (FGB) in GC tissues. Retrospectively we analyzed the data of matched pairs of normal (N) and malignant tissues (T) of 28 consecutive patients with GC at diagnosis by combining one- and two-dimensional electrophoresis (1DE and 2DE) with immunoblotting and mass spectrometry together with two-dimensional difference in gel electrophoresis (2D-DIGE). 1DE showed bands of the intact FGB at 50 kDa and the cleaved forms containing the fragment D at ~37-40 kDa, which corresponded to 19 spots in 2DE. In particular, spot 402 at ~50 kDa and spots 526 and 548 at ~37 kDa were of interest by showing an increased expression in tumor tissues. A higher content of spot 402 was associated with stomach antrum, while spots 526 and 548 amounts correlated with corpus and high platelet count (>208 × 10⁸/L). The quantification of FGB and cleaved products may help to further characterize the interconnections between GC and platelet/coagulation pathways.

Indexed as

ProteomicsAdultAgedCarcinomaCarrier ProteinsComputational BiologyDatabases, ProteinElectrophoresis, Gel, Two-DimensionalFemaleFibrinogenHumansMaleMass SpectrometryMiddle AgedProtein BindingProtein Processing, Post-TranslationalCarrier ProteinsFibrinogenProtein Subunitsbiomarkercoagulationcomparative proteomicsDIGEFGBfibrinogen β chaingastric cancerplatelets

Identifiers

PMID29518939
PMCPMC5877620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.